China SXT Pharmaceuticals (SXTC) Other Accumulated Expenses (2018 - 2025)

China SXT Pharmaceuticals' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $674391.0 for Q1 2025.

• In Q1 2025, Other Accumulated Expenses rose 86.53% year-over-year to $674391.0; the TTM figure through Mar 2025 stood at $674391.0 (up 86.53% YoY), while the FY2025 annual figure was $674391.0, up 86.53% from the prior year.
• Other Accumulated Expenses was $674391.0 for Q1 2025 at China SXT Pharmaceuticals, up from $361543.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q1 2022 to a low of $361543.0 in Q1 2024.
• Historically, Other Accumulated Expenses has averaged $761430.6 across 5 years, with a median of $789232.0 in 2023.
• The sharpest annual moves came in 2021 and 2024: Other Accumulated Expenses soared 184.9% in 2021, then sank 54.19% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $819677.0 in 2021, then surged by 41.8% to $1.2 million in 2022, then slumped by 32.1% to $789232.0 in 2023, then tumbled by 54.19% to $361543.0 in 2024, then jumped by 86.53% to $674391.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $674391.0 (Q1 2025), $361543.0 (Q1 2024), and $789232.0 (Q1 2023), per Business Quant data.